Form 4 Tracker
Erick Lucera

Chief Financial Officer · 2 filings · Latest: May 13, 2026

Dyne Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
DYN
Erick LuceraChief Financial OfficerMay 13, 2026
Sale
$18.361,448$26.6K123,925
DYN
Erick LuceraChief Financial OfficerApr 1, 2026
Sale
$18.645,727$106.8K125,373